2nd Quarter - Report

VAN FLEET ASSOCIATES for KIRK PHARMACEUTICALS

Period 2nd Quarter 2008 Filed Jul 16, 2008 Signed by Paul F. Payette, VP

Official filing
Firm
VAN FLEET ASSOCIATES
Client
KIRK PHARMACEUTICALS
Income
$9,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA DEA regulations pertaining to over the counter drug sales.

LobbyistCovered position, as disclosed
WALTER SANDERS —

Contacted: Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.